Showing 141 - 160 results of 1,014 for search 'development reprogramming', query time: 0.10s Refine Results
  1. 141

    Metabolic reprogramming induced by fructose promotes therapy´s failure in liver cancer cells in vitro and in vivo. by Lisette Chávez-Rodríguez, Oscar A. Escobedo Calvario, Johann Matschke, Verena Jendrossek, Felipe Masso, Araceli Páez Arenas, María C. Gutiérrez-Ruíz, Luis E. Gomez-Quiroz

    Published 2025-04-01
    “…Introduction and Objectives: Metabolic reprogramming is a hallmark of cancer cells. Fructose metabolism is decreased in liver cancer cells to counteract the oxidative environment induced by fructose. …”
    Get full text
    Article
  2. 142

    Macrophage Polarisation in the Tumour Microenvironment: Recent Research Advances and Therapeutic Potential of Different Macrophage Reprogramming by Rongqi Guo PhD, Rui Wang PhD, Weisong Zhang PhD, Yangyang Li PhD, Yihao Wang PhD, Hao Wang PhD, Xia Li PhD, Jianxiang Song PhD

    Published 2025-01-01
    “…Conclusions Understanding the mechanisms underlying macrophage polarisation and reprogramming offers promising avenues for developing therapies to counteract tumour progression. …”
    Get full text
    Article
  3. 143

    Bioengineered hybrid dual-targeting nanoparticles reprogram the tumour microenvironment for deep glioblastoma photodynamic therapy by Rongrong Zhao, Ying Hou, Boyan Li, Ziwen Pan, Jiawei Qiu, Qingtong Wang, Yanhua Qi, Zhe Han, Hongyu Zhao, Hong Liu, Weijia Zhou, Gang Li, Hao Xue

    Published 2025-08-01
    “…Crucially, the platform concurrently induces immunogenic death in tumour cells and reprograms protumoral macrophages to antitumor phenotypes. …”
    Get full text
    Article
  4. 144
  5. 145
  6. 146

    Comprehensive Multiomic Analysis Reveals Metabolic Reprogramming Underlying Human Fontan‐Associated Liver Disease by Rasheed Sule, Po Hu, Clarissa Shoffler, Christopher Petucci, Benjamin J. Wilkins, Jack Rychik, Liming Pei

    Published 2025-03-01
    “…Almost all patients with Fontan operation develop liver fibrosis at a young age, known as Fontan‐associated liver disease (FALD). …”
    Get full text
    Article
  7. 147
  8. 148
  9. 149
  10. 150
  11. 151

    Inhibition of Rho GEFs attenuates pulmonary fibrosis through suppressing myofibroblast activation and reprogramming profibrotic macrophages by Chengju Luo, Chenqi Huang, Yuqi Zhu, Yuxin Zhou, Yansheng Qiao, Chenxiao Shi, Yuan Gao, Yongjian Guo, Libin Wei

    Published 2025-04-01
    “…The dysregulations of Rho GTPases/ROCK are related with various diseases, including fibrosis. Nevertheless, the development of drugs for pulmonary fibrosis treatment has predominantly concentrated on ROCK inhibitors. …”
    Get full text
    Article
  12. 152

    Epigenetic regulation of reprogramming and pluripotency: insights from histone modifications and their implications for cancer stem cell therapies by Woori Bae, Eun A. Ra, Eun A. Ra, Myon Hee Lee

    Published 2025-03-01
    “…Recent studies underscore the importance of epigenetic regulators in both the reprogramming process and the regulation of cancer stem cells (CSCs), which are pivotal in tumor initiation and the development of treatment resistance. …”
    Get full text
    Article
  13. 153

    Epstein-Barr virus reactivation induces divergent abortive, reprogrammed, and host shutoff states by lytic progression. by Elliott D SoRelle, Lauren E Haynes, Katherine A Willard, Beth Chang, James Ch'ng, Heather Christofk, Micah A Luftig

    Published 2024-10-01
    “…While benign in most people, EBV is responsible for infectious mononucleosis, up to 2% of human cancers, and is a trigger for the development of multiple sclerosis. Following latency establishment in B cells, EBV reactivates and is shed in saliva to enable infection of new hosts. …”
    Get full text
    Article
  14. 154

    Acute kidney injury through a metabolic lens: pathological reprogramming mechanisms and clinical translation potential by Jingli Gao, Liuyifei Huang, Yuzhan Zhang, Lei Wei, Zhixiang Yu, Yan Xing, Jinguo Yuan, Xiaoxuan Ning, Shiren Sun

    Published 2025-06-01
    “…Acute kidney injury (AKI) represents a clinical syndrome with a bleak short-term prognosis, posing a high risk for the development of chronic kidney diseases and end-stage kidney disease. …”
    Get full text
    Article
  15. 155

    A Self-Assembled Metabolic Regulator Reprograms Macrophages to Combat Cytokine Storm and Boost Sepsis Immunotherapy by Junyan Zhuang, Yongrui Hai, Xintong Lu, Borui Sun, Renming Fan, Bingjie Zhang, Wenhui Wang, Bingxue Han, Li Luo, Le Yang, Chun Zhang, Minggao Zhao, Gaofei Wei

    Published 2025-01-01
    “…In sepsis models, LDO effectively attenuates CCL2-driven cytokine storms, alleviates acute lung injury, and significantly enhances survival via metabolic reprogramming. This study offers a cytokine-regulatory strategy rooted in immunometabolism, providing a foundation for the translational development of immune metabolite-based sepsis therapies.…”
    Get full text
    Article
  16. 156
  17. 157
  18. 158

    Cytokine-induced reprogramming of human macrophages toward Alzheimer’s disease-relevant molecular and cellular phenotypes in vitro by Anna Podleśny-Drabiniok, Carmen Romero-Molina, Tulsi Patel, Wen Yi See, Yiyuan Liu, Edoardo Marcora, Alison M. Goate

    Published 2025-07-01
    “…These findings provide insights into cytokine-mediated reprogramming of macrophages toward disease-relevant states, highlighting their role in neurodegenerative diseases and potential for therapeutic development.…”
    Get full text
    Article
  19. 159

    Metabolic Reprogramming of Gastric Cancer Revealed by a Liquid Chromatography–Mass Spectrometry-Based Metabolomics Study by Lina Zhou, Benzhe Su, Zexing Shan, Zhenbo Gao, Xingyu Guo, Weiwei Wang, Xiaolin Wang, Wenli Sun, Shuai Yuan, Shulan Sun, Jianjun Zhang, Guowang Xu, Xiaohui Lin

    Published 2025-03-01
    “…Understanding the metabolic reprogramming associated with GC is crucial for the prevention and treatment of this disease. …”
    Get full text
    Article
  20. 160